UBS Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $236K | Sell |
|
|||||
|
2020
Q1 | $917K | Buy |
|
|||||
|
2019
Q4 | $638K | Sell |
|
|||||
|
2019
Q3 | $5.06M | Sell |
|
|||||
|
2019
Q2 | $5.23M | Buy |
|
|||||
|
2019
Q1 | $5.09M | Sell |
|
|||||
|
2018
Q4 | $6.54M | Buy |
|
|||||
|
2018
Q3 | $4.13M | Buy |
|
|||||
|
2018
Q2 | $2.78M | Sell |
|
|||||
|
2018
Q1 | $4.81M | Buy |
|
|||||
|
2017
Q4 | $2.32M | Sell |
|
|||||
|
2017
Q3 | $3.11M | Buy |
|
|||||
|
2017
Q2 | $603K | Buy |
|
|||||
|
2017
Q1 | $187K | Buy |
|
|||||
|
2016
Q4 | $56K | Sell |
|
|||||
|
2016
Q3 | $70K | Sell |
|
|||||
|
2016
Q2 | $786K | Buy |
|
|||||
|
2016
Q1 | $72K | Sell |
|
|||||
|
2015
Q4 | $1.29M | Sell |
|
|||||
|
2015
Q3 | $1.19M | Buy |
|
|||||
|
2015
Q2 | $101K | Sell |
|
|||||
|
2015
Q1 | $139K | Buy |
|
|||||
|
2014
Q4 | $90K | Buy |
|